WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ARWR

Based on 8 analysts offering 12 month price targets for Arrowhead Pharmaceuticals Inc.
Min Forecast
$31.00-3.16%
Avg Forecast
$60.13+87.83%
Max Forecast
$90.00+181.16%

Should I buy or sell ARWR stock?

Based on 8 analysts offering ratings for Arrowhead Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 50%
Buy
2 analysts 25%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARWR stock forecasts and price targets.

ARWR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 3%
3
BuyMaintains$90.00+181.16%2022-12-06
B. Riley Securities
Top 1%
100
Strong BuyMaintains$59.00+84.32%2022-11-30
Jefferies
Bottom 11%
11
Strong BuyMaintains$75.00+134.30%2022-11-29
Morgan Stanley
Bottom 19%
19
HoldMaintains$37.00+15.59%2022-11-29
SVB Leerink
Bottom 1%
1
HoldMaintains$31.00-3.16%2022-11-29
Piper Sandler
Top 20%
81
Strong BuyMaintains$64.00+99.94%2022-11-10
Goldman Sachs
Top 2%
99
Strong BuyMaintains$65.00+103.06%2022-08-08
Anonymous
Goldman Sachs
Strong BuyMaintains$66.00+106.19%2022-05-24
Baird
Top 18%
83
BuyUpgrades$60.00+87.44%2022-05-11

1 of 1

Forecast return on equity

Is ARWR forecast to generate an efficient return?
Company
30.86%
Industry
15.35%
Market
62.84%
ARWR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARWR forecast to generate an efficient return on assets?
Company
17.77%
Industry
13.55%
ARWR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARWR earnings per share forecast

What is ARWR's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$1.47
Avg 2 year Forecast
-$1.81
Avg 3 year Forecast
$1.16

ARWR revenue forecast

What is ARWR's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$284.0M+16.77%
Avg 2 year Forecast
$308.3M+26.73%
Avg 3 year Forecast
$549.5M+125.9%
ARWR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARWR revenue growth forecast

How is ARWR forecast to perform vs Biotechnology companies and vs the US market?
Company
27.19%
Industry
24.83%
Market
6.69%
ARWR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARWR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARWR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARWR$32.01$60.13+87.83%Strong Buy
VIR$25.62$49.60+93.60%Hold
PCVX$43.22$69.00+59.65%Strong Buy
FOLD$12.25$14.50+18.37%Buy
ZLAB$34.00$100.33+195.10%Strong Buy

Arrowhead Pharmaceuticals Stock Forecast FAQ

Is Arrowhead Pharmaceuticals Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ARWR) stock is to Strong Buy ARWR stock.

Out of 8 analysts, 4 (50%) are recommending ARWR as a Strong Buy, 2 (25%) are recommending ARWR as a Buy, 2 (25%) are recommending ARWR as a Hold, 0 (0%) are recommending ARWR as a Sell, and 0 (0%) are recommending ARWR as a Strong Sell.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.

What is ARWR's earnings growth forecast for 2023-2025?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Arrowhead Pharmaceuticals's earnings in 2022 is -$176,063,000.On average, 8 Wall Street analysts forecast ARWR's earnings for 2023 to be -$155,828,411, with the lowest ARWR earnings forecast at -$436,743,575, and the highest ARWR earnings forecast at $106,005,722. On average, 4 Wall Street analysts forecast ARWR's earnings for 2024 to be -$191,870,357, with the lowest ARWR earnings forecast at -$406,001,915, and the highest ARWR earnings forecast at -$43,462,346.

In 2025, ARWR is forecast to generate $122,966,638 in earnings, with the lowest earnings forecast at $62,543,376 and the highest earnings forecast at $183,389,899.

What is ARWR's revenue growth forecast for 2023-2025?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's forecast annual revenue growth rate of 27.19% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Arrowhead Pharmaceuticals's revenue in 2022 is $243,231,000.On average, 7 Wall Street analysts forecast ARWR's revenue for 2023 to be $30,107,109,128, with the lowest ARWR revenue forecast at $9,922,135,579, and the highest ARWR revenue forecast at $62,691,783,991. On average, 4 Wall Street analysts forecast ARWR's revenue for 2024 to be $32,676,263,807, with the lowest ARWR revenue forecast at $15,763,050,861, and the highest ARWR revenue forecast at $53,405,682,744.

In 2025, ARWR is forecast to generate $58,246,540,044 in revenue, with the lowest revenue forecast at $17,586,349,280 and the highest revenue forecast at $83,977,732,968.

What is ARWR's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: ARWR) forecast ROA is 17.77%, which is higher than the forecast US Biotechnology industry average of 13.55%.

What is ARWR's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ARWR price target, the average ARWR price target is $60.13, with the highest ARWR stock price forecast at $90.00 and the lowest ARWR stock price forecast at $31.00.

On average, Wall Street analysts predict that Arrowhead Pharmaceuticals's share price could reach $60.13 by Dec 6, 2023. The average Arrowhead Pharmaceuticals stock price prediction forecasts a potential upside of 87.83% from the current ARWR share price of $32.01.

What is ARWR's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's current Earnings Per Share (EPS) is -$1.67. On average, analysts forecast that ARWR's EPS will be -$1.47 for 2023, with the lowest EPS forecast at -$4.12, and the highest EPS forecast at $1.00. On average, analysts forecast that ARWR's EPS will be -$1.81 for 2024, with the lowest EPS forecast at -$3.83, and the highest EPS forecast at -$0.41. In 2025, ARWR's EPS is forecast to hit $1.16 (min: $0.59, max: $1.73).

What is ARWR's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: ARWR) forecast ROE is 30.86%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.